The global market for next generation sequencing for non-invasive prenatal testing market has gained momentum in recent times. The efforts of gynecologists and health experts to educate mothers about the importance of prenatal testing has popularized the market. Prenatal testing gives information about the health of pregnant mothers, and also helps in determining the possibility of any disorders or syndromes in the baby. Down syndrome, Patau syndrome, and Edward’s syndrome are some of the disorders that can be detected with the help of prenatal testing. The accuracy and safety offered by next generation sequencing for non-invasive prenatal testing has been the key factor behind the growth of the market. A report by Transparency Market Research (TMR) scrutinizes the global market in order to foretell the growth prospects for the future. The report titled ‘Next-Generation Sequencing for Non-Invasive Prenatal Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024’ gives several key standpoints from the perspective of market growth.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14135
DNA sequencing is costly, which has risen the demand for next generation sequencers that can yield a large number of sequences in a single run. The department of biology at the Copenhagen points to over 7000 rare diseases caused by genetic changes, and a large number of those lack treatment mechanisms. Through effective next-generation sequencing, the causative genes for these disorders and diseases can be studied followed by the development of treatments. Hence, the demand is expected to experience a tremendous push in the coming years.
The prominence of a regional market for next-generation non-invasive prenatal testing depends upon the number of cases of prenatal disorders. The market in Europe and North America experiences an increased number of such cases, thus, propelling demand within these regions. Other regional segments include the Middle East and Africa, Asia Pacific, and Latin America.
Illumina, Inc., Inc, Biomatters, Ltd., and Agilent Technologies are few of the key market players in the cotemporary times.